Showing results (141-150 of 259) with videos related to
Sort By:
Pageof 26
Expert Review of Clinical Pharmacology|May 11, 2019
A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patientsGeorgios Schoretsanitis, John M Kane, Can-Jun Ruan, et al.BMC Psychiatry|January 29, 2011
Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive DisorderAndré Tadić, Stefanie Wagner, Stanislav Gorbulev, et al.British Journal of Clinical Pharmacology|February 5, 2017
Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacyMichael Paulzen, Ekkehard Haen, Christoph Hiemke, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 21, 2017
Pharmacokinetics of risperidone in different application forms - Comparing long-acting injectable and oral formulationsGeorgios Schoretsanitis, Jose de Leon, Ekkehard Haen, et al.Expert Review of Clinical Pharmacology|March 31, 2025
Effects of the augmentation with quetiapine or olanzapine on the metabolism of duloxetine: a retrospective analysisNele Römer, Arnim Johannes Gaebler, Irene Neuner, et al.Psychoneuroendocrinology|July 25, 2016
Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; A pharmacokinetics-based hypothesisMichael Paulzen, Ekkehard Haen, Benedikt Stegmann, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 13, 2021
Current use of anticholinergic medications in a large naturalistic sample of psychiatric patientsSermin Toto, Gudrun Hefner, Martina Hahn, et al.Frontiers in Psychiatry|December 13, 2021
Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic ReviewsXenia M Hart, Luzie Eichentopf, Xenija Lense, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|September 28, 2018
Therapeutic Drug Monitoring of Naltrexone and 6β-Naltrexol During Anti-craving Treatment in Alcohol Dependence: Reference RangesSonja Brünen, Nina Kim Bekier, Christoph Hiemke, et al.Therapeutic Drug Monitoring|July 2, 2004
Therapeutic monitoring of new antipsychotic drugsChristoph Hiemke, Aleksandra Dragicevic, Gerhard Gründer, et al.Pageof 26